--- title: "BiomX (PHGE.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/PHGE.US/norm.md" symbol: "PHGE.US" name: "BiomX" parent: "https://longbridge.com/en/quote/PHGE.US.md" datetime: "2026-05-20T20:35:35.436Z" locales: - [en](https://longbridge.com/en/quote/PHGE.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/PHGE.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/PHGE.US/norm.md) --- # BiomX (PHGE.US) — Financial Reports ## Income Statement (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | EPS | -6.67 | -5.55 | -3.66 | -6.30 | -13.27 | | ROE | 380.38% | 962.81% | -758.30% | -539.51% | -469.03% | | Revenue | - | - | - | - | - | | Net income | -13.34M | -9.17M | -6.04M | -7.66M | -14.51M | | Operating income | -7.20M | -8.54M | -7.43M | -7.76M | -9.39M | | Gross margin | - | - | - | - | - | | Net margin | - | - | - | - | - | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 5.78M | 26.17M | 38.05M | 45.65M | 43.23M | | Leverage | -4.44 | 2.50 | 1.99 | 1.86 | 1.79 | | BVPS | -12.50 | -5.76 | 0.3700 | 4.46 | 5.75 | | Turnover | - | - | - | - | - | | Cash & STI | 4.36M | 6.92M | 14.05M | 20.12M | 16.86M | | Inv & Rec | - | - | - | - | - | | LT assets | - | 5.09M | 9.20M | 9.91M | 10.50M | | Net debt | -2.92M | -340000.00 | -4.67M | -10.82M | -7.27M | ## Cash Flow Statement (USD) | Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | -4.39M | -7.18M | -6.11M | -8.71M | -6.29M | | Investing CF | 1000.00 | -2000.00 | 58000.00 | 51000.00 | -1000.00 | | Financing CF | 1.25M | 54000.00 | -29000.00 | 11.91M | -398000.00 | | Free CF | -1.31M | -4.11M | -3.68M | -4.96M | -3.79M | | OCF coverage | - | -359150.00% | - | - | -57172.73% | | Repaid & issued | - | - | - | - | - | | CapEx | 0.0000 | -2000.00 | - | - | -11000.00 |